Hpv

Can a contraceptive drug really prevent and cure cervical cancer?

Cervical cancer is the fourth most common cancer as well as the fourth leading cause of cancer deaths in women worldwide.

Why is a vaccine that would drastically reduce the incidence of cervical cancer not a part of India's universal immunisation programme

Cervical cancer is strongly linked to certain strains of HPV. Two strains of HPV, HPV 16 and 18, cause over 70% of cases of the disease in India.

UK-based doctors develop simple kit to test cervical cancer; ailment claims almost 270,000 lives every year

Checking for cervical cancer may soon become as easy as collecting a vaginal swab at home, in the privacy of your bathroom, Public Health England has already started a small-scale preliminary study for a home smear test

World Health Day 2019: A quick guide to Cervical Cancer and how to prevent it

Cervical cancer is the fourth most diagnosed cancer in women and a key cause of preventable deaths.

Cancer drugs may be repurposed to allow infections caused by HPV to be treated, say scientists

HPV infections caused an estimated 266,000 deaths from cervical cancer worldwide in 2012, according to the World Health Organization (WHO)

Indian scientists are testing dendritic therapy in the fight against cervical cancer

Cancer of the uterine cervix, also known as cervical cancer, is the second leading cause of cancer deaths among women in India.

Re-evaluating the 'cost' of life: Cancer-preventing HPV vaccines are substantially over-priced, says study

A recent study revealed that the manufacturing costs for two most prevalent HPV cancer vaccines could be priced much lower than the quoted ‘no profit’ price

US study throws up new vaccine to prevent cervical cancer

A new human papillomavirus (HPV) vaccine can potentially prevent 80 percent of cervical cancers if given to all 11- or 12-year-old children

Biocon reports Q3 net profit of Rs 105 cr, up 14%

The key highlight was the DCGI approval for our biosimilar Trastuzumab, which paved the way for its commercial launch in India as CANMAb.<br /><br />

Study claims to identify strain of cervical cancer virus that causes throat cancer

The latest study has results suggests that HPV16 E6 antibodies in the blood indicate a very high risk of developing an HPV-associated cancer of the oropharynx.